This inventor holds 1 USPTO granted patent. Top assignee: Beth Israel Deaconess Medical Center, Inc.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Jody Dushay: Innovator in Fructose Metabolism Research
Introduction
Jody Dushay is an accomplished inventor based in Newton, MA (US). He has made significant contributions to the field of metabolism research, particularly in understanding fructose metabolism. His innovative work has led to the development of a patent that addresses important health issues related to metabolic disorders.
Latest Patents
Jody Dushay holds a patent titled "Measurement of FGF21 as a biomarker of fructose metabolism." This invention provides methods for monitoring the fructose response of a subject by determining the level of fibroblast growth factor 21 (FGF21) gene expression product in a biological sample, such as serum. The invention is particularly useful for subjects who have been administered a fructose bolus. Additionally, it offers methods for monitoring a subject's response to treatment for metabolic disorders, discriminating fructose intolerance from other gastrointestinal disorders, and identifying individuals at risk for developing metabolic disorders.
Career Highlights
Dushay is affiliated with Beth Israel Deaconess Medical Center, Inc., where he continues to advance research in metabolic health. His work has implications for improving the diagnosis and treatment of metabolic disorders, which are increasingly prevalent in today's society.
Collaborations
Some of Jody Dushay's notable coworkers include Eleftheria Maratos-Flier and Mark A Herman. Their collaborative efforts contribute to the ongoing research and development in the field of metabolism.
Conclusion
Jody Dushay's innovative work in fructose metabolism and his patent on FGF21 as a biomarker highlight his significant contributions to medical research. His efforts are paving the way for better understanding and treatment of metabolic disorders.